Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 9854893, 11 pages
https://doi.org/10.1155/2017/9854893
Review Article

Moxibustion for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis

1Department of Acupuncture, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
2Beijing University of Chinese Medicine, Beijing 100029, China

Correspondence should be addressed to Zhishun Liu; moc.nuyila@nuhsihzuil

Received 8 June 2017; Revised 27 July 2017; Accepted 5 September 2017; Published 12 October 2017

Academic Editor: Kieran Cooley

Copyright © 2017 Ziling Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Oncology ASCO, “American Society of Clinical Oncology guideline for antiemetic in oncology: update 2006,” Journal of Clinical Oncology, vol. 24, pp. 2932–2947, 2006. View at Google Scholar
  2. K. Jordan, R. Gralla, F. Jahn, and A. Molassiotis, “International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): content and implementation in daily routine practice,” European Journal of Pharmacology, vol. 722, no. 1, pp. 197–202, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. C. Tricco, E. Blondal, A. A. Veroniki et al., “Comparative safety and effectiveness of serotonin receptor antagonists in patients undergoing chemotherapy: A systematic review and network meta-analysis,” BMC Medicine, vol. 14, no. 1, article no. 216, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Moradian and D. Howell, “Prevention and management of chemotherapy-induced nausea and vomiting,” International Journal of Palliative Nursing, vol. 21, no. 5, pp. 216–224, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Tageja and H. Groninger, “Chemotherapy-induced nausea and vomiting #285,” Journal of Palliative Medicine, vol. 17, no. 12, pp. 1400–1402, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. National Comprehensive Cancer Network, “NCCN clinical practice guidelines in Oncology. Antiemesis,” 2014, https://www.nccn.org/professionals/physician_gls/PDF/antiemesis.pdf.
  7. R. J. Gralla, D. Osoba, M. G. Kris et al., “Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines,” Journal of Clinical Oncology, vol. 17, no. 9, pp. 2971–2994, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. M. C. Janelsins, M. A. Tejani, C. Kamen, A. R. Peoples, K. M. Mustian, and G. R. Morrow, “Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients,” Expert Opinion on Pharmacotherapy, vol. 14, no. 6, pp. 757–766, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Herrstedt, “Chemotherapy-induced nausea and vomiting: ESMO Clinical Recommendations for prophylaxis,” Annals of Oncology, vol. 18, no. 2, pp. ii83–ii85, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. K. V. Rao and A. Faso, “Chemotherapy-induced nausea and vomiting: Optimizing prevention and management,” American Health and Drug Benefits, vol. 5, no. 4, 2012. View at Google Scholar · View at Scopus
  11. J. Xu, H. Deng, and X. Shen, “Safety of moxibustion: a systematic review of case reports,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 783704, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. M. S. Lee, T.-Y. Choi, J.-E. Park, S.-S. Lee, and E. Ernst, “Moxibustion for cancer care: A systematic review and meta-analysis,” BMC Cancer, vol. 10, article no. 130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Yuyu and X. Zhai, “Moxibustion for cancer-related symptoms: a systematic review and meta-analysis,” in Proceedings of the Annual Meeting of National Chinese Medicine Tumor Academic, Beijing, China, 2013.
  14. S. Gao, The clinical research on myelosuppression after chemotherapy treats by wheat moxibustion, NanJing University of Chinese Medicine, NanJing, China, 2015.
  15. Z. Hao, Clinical observation on immune function in patients with mild moxibustion cancer chemotherapy, NanJing University of Chinese Medicine, NanJing, China, 2014.
  16. J. Liang, “Efficacy of moxibustion with ginger in alleviating side effects of lung chemotherapy,” Guangming Journal of Chinese Medicine, vol. 29, pp. 1841-1842, 2014. View at Google Scholar
  17. S. Liu, Clinical study on the efficiency of direct contact moxibustion on toxicity and side effects resulted from chemotherapy, Guangzhou University of Chinese Medicine, 2010.
  18. Y. Ruan, W. X. Zhang, W. Xa, Q. Gu, J. Jiao, and L. Liu, “Effect of herb-partitioned moxibustion on chemotherapy-induced nausea and vomiting of gastric cancer,” Chinese Archives of Traditional Chinese Medicine, vol. 32, pp. 2664–2666, 2014. View at Google Scholar
  19. T. Wang, The impact on the toxic reaction of the chemotherapeutics by direct moxibustion on four flowers acupoint, Guangzhou University of Chinese Medicine, 2010.
  20. W. Zhou, J. Kao, C. Yu, and X. Ma, “Clinical observation on moxibusion at zusanli point to treat delayed vomiting caused by Cisplatin,” Journal of Clinical Acupuncture and Moxibustion, vol. 21, pp. 47-48, 2005. View at Google Scholar
  21. P. Xiang, “The clinical study of moxibustion alleviating nausea and vomiting by colon chemoradiotherapy,” Journal of Emergency in Traditional Chinese Medicine, vol. 20, pp. 1327-1328, 2011. View at Google Scholar
  22. S. A. Xu, J. Yang, and B. Zhao, “Possible Therapeutic effect of ginger-partitioned moxibustion on chemotherapy induced toxic side effects and quality of life scale: a clinical observation,” Global Traditional Chinese Medicine, vol. 7, pp. 901–905, 2014. View at Google Scholar
  23. S. Zhong, S. Xu, B. Xu, Y. Sun, and H. Tian, “Clinical Study on Moxibustion Combined with Granisetron Hydrochloride Injection in the Treatment of Nausea and Vomiting Caused by Chemotherapy of Breast Cancer,” Journal of Chinese Medicinal Materials, vol. 34, no. 6, pp. 1007–1009, 2011. View at Google Scholar
  24. Q. Zhang, L. Li, and D. Fan, “Effect of Direct Moxibustion and Four - flower Point on Quality of Life of Chemotherapy Patients with Lung Cancer,” Journal of Practical Traditional Chinese Medicine, vol. 32, no. 10, pp. 1006-1007, 2016. View at Google Scholar
  25. X. Zhang, Efficacy of moxibustion with ginger in preventing toxicity of chemotherapy and effect on quality of life on cancer, GuangZhou University of Chinese Medicine, 2008.
  26. Z. Zhong, Clinical study of treating side effects of chemotherapy of lung cancer by ginger moxibustion on Sihua acupoint, GuangZhou University of Chinese Medicine, 2014.
  27. Q. Li, M. Zhong, X. Ye, R. Tang, X. Tan, and R. Li, “Investigation of vomiting-stopping efficacy of moxa box moxibustion in chemotherapy of platinum-based drugs,” Clinical Journal of Chinese Medicine, vol. 7, pp. 120-121, 2015. View at Google Scholar
  28. E. H. T. Ya, Clinical and experimental studies of moxa at guanyuan on effects of the chemotherapy patients vital signs, Guangzhou University of Chinese Medicine, 2010.
  29. Y. Zhang, T. Kong, and H. Zhou, “Moxibustion in treatment of gastrointestinal adverse effects of patients with non-small cell lung cancer in chemotherapy,” Journal of Chinese Medicine, vol. 31, pp. 1265-1266, 2016. View at Google Scholar
  30. J. P. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, The Cochrane Collaboration, 2011. View at Publisher · View at Google Scholar
  31. J. P. T. Higgins, D. G. Altman, P. C. Gøtzsche et al., “The Cochrane Collaboration's tool for assessing risk of bias in randomised trials,” The British Medical Journal, vol. 343, no. 7829, Article ID d5928, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. L. S. Schwartzberg, M. R. Modiano, B. L. Rapoport et al., “Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: A randomised, active-controlled, double-blind, phase 3 trial,” The Lancet Oncology, vol. 16, no. 9, article no. 37, pp. 1071–1078, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. J. E. Kim, Y. S. Hong, J.-L. Lee et al., “A randomized study of the efficacy and safety of transdermal granisetron in the control of nausea and vomiting induced by moderately emetogenic chemotherapy in Korean patients,” Supportive Care in Cancer, vol. 23, no. 6, pp. 1769–1777, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. D. L. Barton, G. Thanarajasingam, J. A. Sloan et al., “Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance),” Cancer, vol. 120, no. 22, pp. 3575–3583, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. B.-X. Zhao, H.-Y. Chen, X.-Y. Shen, and L. Lao, “Can moxibustion, an ancient treatment modality, be evaluated in a double-blind randomized controlled trial? - A narrative review,” Journal of Chinese Integrative Medicine, vol. 12, no. 3, pp. 131–134, 2014. View at Publisher · View at Google Scholar · View at Scopus